Recursion Pharmaceuticals Inc's (NYSE: RXRX) short interest as a percent of float has fallen 15.85% since its last report.

Learn more about whether Immunocore Holdings plc or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Etien Yovchev is the co-founder and managing partner of The Recursive, a tech media covering trends in Europe's AI economy.

There’s a persistent stereotype that developers don’t have friends, don’t go outside, don’t attend social events, and don’t ...